clinical outcomes of allegra tavi system in aortic valve disease patients - pcr valves e-course 2020
Published 4 years ago • 2.3K plays • Length 37:16Download video MP4
Download video MP3
Similar videos
-
1:00:25
optimal tavi outcomes in the active patient - pcr valves e-course 2020
-
14:46
the uncompromised hemodynamics of the allegra™ transfemoral tavi system - pcr london valves 2021
-
1:02:22
optimizing your tavi procedure in the covid-19 era - pcr valves e-course 2020
-
4:52
#pcrvalves ecourse highlights day 1: the aortic valve!
-
54:59
double jeopardy: coronary disease in patients undergoing tavi - europcr 2022
-
2:29
outcomes of repeat tavr with balloon-expandable valves - europcr 2023
-
44:53
maintaining selective coronary access after tavi and re-do tavi procedures - pcr london valves 2022
-
1:22:13
new frontiers in tavi: have we reached them? pcr london valves 2024
-
1:00:00
how to ensure coronary access after transcatheter aortic valve implantation? - webinar
-
46:59
a problem and a solution: aortic regurgitation and the trilogy tavi valve - pcr london valves 2023
-
1:04:49
optimising procedural outcomes of tavi in challenging anatomies - webinar
-
56:54
how should heart teams adapt to recently-updated valvular heart disease guidelines? - webinar
-
5:10
europcr 2019: allegra transcatheter heart valve shows “very good haemodynamic outcomes”
-
1:25:31
valve performance and durability - main considerations in selecting the right tavi valve
-
41:26
a new evolution in treatment: tavr for aortic regurgitation with the jenavalve trilogy system
-
5:05
focus on aortic valve disease - pcr london valves 2024 #pcrlv
-
21:34
tavr using allegra self expandable 27 mm valve
-
1:00
bch health segment: fda expands access of tavr for heart valve disease
-
6:42
tavi: all you need to know